Welcome to our dedicated page for Innospec SEC filings (Ticker: IOSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Innospec Inc. (NASDAQ: IOSP), an international specialty chemicals company. These documents offer detailed information about the company’s operations across its Performance Chemicals, Fuel Specialties and Oilfield Services segments, as well as its capital structure and governance.
Innospec’s SEC filings include periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which present audited or reviewed financial statements, segmental data and discussions of results. Investors use these filings to examine net sales, gross profit and operating income by segment, along with notes on research and development, corporate costs and regional performance.
The company also files current reports on Form 8-K to disclose material events. Recent 8-K filings have covered the release of quarterly financial results and the declaration of semi-annual dividends on IOSP common stock. These filings identify the NASDAQ listing for Innospec’s common shares and provide details such as record and payment dates for dividends.
On Stock Titan, Innospec’s filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the key points in lengthy documents. Users can quickly see which items relate to earnings, dividend actions, segment performance or other notable events. For those interested in topics such as non-GAAP measures, net cash, or segment trends in Performance Chemicals, Fuel Specialties and Oilfield Services, the filings page offers a structured way to review the company’s regulatory disclosures.
By combining real-time access to IOSP filings with AI-generated highlights, this page helps readers navigate Innospec’s official reporting without needing to read every line of each document.
Innospec’s Q2 2025 10-Q shows mixed performance. Net sales rose 1% YoY to $439.7 m, but net income fell 25% to $23.5 m (EPS $0.94). Lower profitability stemmed from a 120 bp drop in aggregate gross margin to 28.0% and a 3% rise in operating expenses; operating income declined 16% to $34.3 m.
Segment results were uneven: Fuel Specialties boosted gross margin 350 bp to 38.1% and operating income 16% to $35.4 m, while Performance Chemicals margin contracted 510 bp and Oilfield Services revenue fell 7%. For the first half, sales slipped 6% to $880.5 m and net income dropped 22% to $56.3 m (diluted EPS $2.24).
Cash from operations shrank to $37.6 m (-56% YoY) as inventories climbed $35.8 m. Nevertheless, cash & equivalents remain solid at $266.6 m; the $250 m revolver is undrawn and the company carries no long-term debt. Equity improved to $1.30 bn on retained earnings and a $57.6 m favorable FX translation adjustment.
Capital deployment included $32.2 m of capex/ERP spend, $20.8 m dividends ($0.84 / share) and $13.3 m share buybacks under a new $50 m program. Plant-closure provisions were raised $4.1 m and FX hedges produced a $6.4 m loss. Management cites softer demand in Oilfield Services and price pressure in Performance Chemicals, but highlights margin gains in Fuel Specialties and low leverage.